Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $364.33 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $119.94 | 12 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $106.90 | 9 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $44.84 | 3 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30.73 | 1 | $0 (2023) |
| The Medicines Company | $21.40 | 1 | $0 (2017) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $17.39 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $11.71 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $11.42 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $30.73 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($30.73) |
| 2018 | $56.23 | 4 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($17.39) |
| 2017 | $277.37 | 24 | PFIZER INC. ($108.52) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $30.73 | General |
| 10/24/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.39 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/10/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/09/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/26/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/12/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.00 | General |
| Category: Cardiovascular | ||||||
| 11/15/2017 | The Medicines Company | VABOMERE (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/19/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.76 | General |
| Category: Cardiovascular | ||||||
| 09/19/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/12/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/25/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.50 | General |
| Category: Cardiovascular | ||||||
| 07/25/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $9.13 | General |
| Category: Cardiovascular | ||||||
| 07/24/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/27/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.70 | General |
| Category: Cardiovascular | ||||||
| 06/20/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/16/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $9.29 | General |
| Category: Cardiovascular | ||||||
| 05/11/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/03/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.61 | General |
| Category: Cardiovascular | ||||||
| 03/30/2017 | PFIZER INC. | ELIQUIS (Drug), CHANTIX | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/22/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.72 | General |
| Category: Cardiovascular | ||||||
| 03/06/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/21/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.19 | General |
| Category: Cardiovascular | ||||||
| 02/20/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/16/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/15/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 479 | 713 | $456,570 | $59,255 |
| 2022 | 10 | 620 | 881 | $637,988 | $83,896 |
| 2021 | 11 | 625 | 941 | $669,297 | $93,176 |
| 2020 | 10 | 703 | 1,129 | $657,808 | $111,253 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 136 | 317 | $135,993 | $19,043 | 14.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 93 | 96 | $115,008 | $12,691 | 11.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 22 | 44 | $57,992 | $7,172 | 12.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 46 | 71 | $43,878 | $6,422 | 14.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 92 | 94 | $40,514 | $5,665 | 14.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 59 | 60 | $37,920 | $5,201 | 13.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 31 | $25,265 | $3,062 | 12.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 159 | 344 | $212,592 | $28,199 | 13.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 97 | 101 | $121,398 | $16,239 | 13.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 33 | 71 | $93,578 | $12,378 | 13.2% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 54 | 54 | $59,130 | $7,640 | 12.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 56 | 57 | $36,024 | $4,676 | 13.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 76 | 80 | $34,480 | $4,487 | 13.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 68 | 68 | $29,172 | $3,695 | 12.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 39 | 60 | $25,740 | $3,358 | 13.0% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 26 | 32 | $19,840 | $2,487 | 12.5% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 12 | 14 | $6,034 | $737.47 | 12.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 143 | 368 | $227,526 | $31,249 | 13.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 98 | 102 | $122,396 | $17,120 | 14.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 37 | 81 | $106,758 | $15,130 | 14.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 56 | 57 | $62,415 | $8,636 | 13.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 91 | 92 | $39,652 | $5,307 | 13.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 73 | 75 | $32,175 | $4,287 | 13.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 37 | 72 | $30,888 | $4,140 | 13.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 36 | 37 | $23,384 | $3,138 | 13.4% |
About Dr. Jitendra Patel, MD
Dr. Jitendra Patel, MD is a Internal Medicine healthcare provider based in Mooresville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2010. The National Provider Identifier (NPI) number assigned to this provider is 1679885511.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jitendra Patel, MD has received a total of $364.33 in payments from pharmaceutical and medical device companies, with $30.73 received in 2023. These payments were reported across 29 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($364.33).
As a Medicare-enrolled provider, Patel has provided services to 2,427 Medicare beneficiaries, totaling 3,664 services with total Medicare billing of $347,581. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist, Hospitalist
- Location Mooresville, NC
- Active Since 07/08/2010
- Last Updated 01/25/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679885511
Products in Payments
- ELIQUIS (Drug) $176.94
- CHANTIX (Drug) $49.90
- ZERBAXA (Drug) $44.84
- VABOMERE (Drug) $21.40
- LifeVest (Device) $17.39
- XARELTO (Drug) $11.71
- ENTRESTO (Drug) $11.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mooresville
Dr. Kobina Wilmot, M.d, M.D
Internal Medicine — Payments: $48,697
Elmer Stout, Md, MD
Internal Medicine — Payments: $23,105
John Gatlin, M.d, M.D
Internal Medicine — Payments: $14,168
Luanne Gatlin, M.d, M.D
Internal Medicine — Payments: $7,171
Dr. Anthony Macasieb, D.o, D.O
Internal Medicine — Payments: $4,754
Christopher Zietlow, Md Phd, MD PHD
Internal Medicine — Payments: $2,012